We report the case of a 38-year-old man who developed fatal, systemic amyloidosis following ankylosing spondylitis. He was admitted for symptoms of congestive heart failure. Based on parotid gland biopsy and echocardiography, he was diagnosed as having systemic amyloidosis following active ankylosing spondylitis. However, the clinical course was rapidly progressive and eventually the patient died of acute necrotizing pancreatitis. The association has been reported thus far in a limited number of cases worldwide. The literature has featured localized lesions and a benign clinical course of the amyloidosis. This case, the first report from Japan, indicates that the amyloidosis associated with ankylosing spondylitis might exhibit a rapidly progressive clinical course, thereby suggesting that in such a case, meticulous treatment is required. (Jpn Heart J 36: 681-688, 1995) Key words: Amyloidosis Ankylosing spondylitis Heart failure Renal failure favorable.1-12) Despite the literature from other countries, there have been no case From the
M UCH knowledge has accumulated relating to the primary diseases causing systemic amyloidosis, which include rheumatoid arthritis and chronic tuberculosis. Ankylosing spondylitis might be associated with amyloidosis of the kidney, rectum or liver vessels, however, since amyloid lesions are reportedly localized to a limited area, the prognosis of this entity is believed to be reports thus far in Japan describing ankylosing spondylitis as a precurser of systemic amyloidosis. In this paper, we report the first Japanese case of amyloidosis following active ankylosing spondylitis, which had systemic lesions and a fatal outcome.
CASE REPORT
A 38-year-old man was admitted to our hospital because of dyspnea and palpitations. He had suffered from back pain since 18 years of age. Two years later he was diagnosed as having ankylosing spondylitis based on radiographic examinations and laboratory data. He had been treated with non-steroidal antiinflammatory drugs since that time. Proteinuria and hypertension became overt one year before admission. In May 1989, he experienced dyspnea and palpitation, both of which became increasingly severe. He was admitted to our hospital on December 6, 1989 . There was no family history of ankylosing spondylitis or amyloidosis. He was 170cm in height and 63kg in weight. Heart rate was 95 beats/minute and blood pressure was 200/100mmHg. The conjunctivae were slightly anemic. The oral labia and mucosa were dry. The thyroid gland was diffusely enlarged and slightly firm. A grade III systolic ejection murmur was found at the apical area. He exhibited a bent posture due to severe kyphosis. Neurological examination was normal. Laboratory data revealed mild leukocytosis and anemia. Blood urea nitrogen was 28milligrams/dl, serum creatinine 2.0milligrams/dl, and total protein 5.9grams/dl. Erythrocyte sedimentation rate (ESR) was 70mm/hour. C-reactive protein (CRP) was 2.2milligrams/ dl. Rheumatoid factor and anti-nuclear antibodies were negative. Thyroid function was normal. Urinary protein excretion was 1.5 to 2.0grams/day. Bence-Jones protein was not detected on immunoelectrophoresis. Human leukocyte antigen (HLA) B-27 was negative. Chest radiography showed mild cardiomegaly (cardiothoracic ratio 51%) and bilateral pleural effusions. Electrocardiograph revealed sinus tachycardia (heart rate 98/min) and a small R and deep S wave in leads V2 to V4. Echocardiography showed symmetric thickening of the interventricular septum (19mm in width) and the posterior left ventricular wall (20mm in width) with mild hypokinesia and granular sparkling of the interventricular septum, indicating the occurrence of amyloid lesions and subsequent dysfunction in cardiac contractility. Aortic valve regurgitation was not evident on a color Doppler examination ( Figure 1 ).
The right parotid gland was biopsied and histological examination showed Congo red-positive amyloid fibrils deposited in the interstitial tissue (Figure 2-a) . More precisely, AA-type amyloid antigens were demonstrated in the deposits, using anti-AA amyloid-specific antibody and the immunoperoxidase method ( Figure 2-b) . Neither AL-nor AF-nor AE-type amyloid was observed in the tissue.
Bone radiography revealed typical lesions of ankylosing spondylitis: bamboo-like vertebrae, sacroiliac joint sclerosis (sacroiliitis), and calcification of the anterior longitudinal ligament of the vertebrae (Figure 3 ).
Because of massive proteinuria and intractable edema, the patient was treated with dimethylsulfoxide (DMSO) and non-steroidal antiinflammatory drugs; however, conventional treatment was ultimately found to be ineffective. Thus, the medication was switched to 40milligrams/day of prednisolone in order to suppress the activity of the underlying spondylitis. This treatment resulted in a marked decrease in the activity of ankylosing spondylitis as shown in the reduction of ESR and CRP and a decrease in plasma creatinine (Figure 4 ). However, he eventually died of acute pancreatitis on April 16, 1990 .
Autopsy findings were as follows. The heart weighed 580 grams. The left ventricular wall was yellowish and showed concentric hypertrophy. Congo redpositive amyloid fibrils were diffusely deposited in the left ventricular wall. Amyloid deposits were also found in the kidney, liver, thyroid gland and pancreas. Moreover, marked destruction and diffuse coagulation necrosis were found in the pancreas, corresponding to the lesions seen in acute necrotizing pancreatitis. The hip, sacroiliac and intervertebral joints exhibited advanced changes corresponding to bony ankylosing spondylitis. The pathological diagnosis was 1) ankylosing spondylitis, 2) generalized amyloidosis and 3) acute necrotizing pancreatitis with peritonitis. 
DISCUSSION

